Aspen Aerogels (ASPN) EBT (2013 - 2026)

Aspen Aerogels has reported EBT for 14 years, with the latest figure at -$23.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 92.02% year-over-year to -$23.9 million; the trailing twelve-month figure through Mar 2026 stood at $278.4 million (up 198.02% YoY), and the FY2025 full-year result was $2.2 million, down 85.74% from the prior year.
• EBT for Q1 2026 stood at -$23.9 million, down from $316.3 million in the prior quarter.
• The five-year high for EBT was $316.3 million in Q4 2025, with the low at -$300.2 million in Q1 2025.
• Historically, EBT has averaged -$8.0 million across 5 years, with a median of -$12.7 million in 2024.
• The largest YoY upside for EBT was 2727.38% in 2025 against a maximum downside of 27719.56% in 2025.
• Aspen Aerogels' EBT stood at -$9.6 million in 2022, then soared by 94.6% to -$519000.0 in 2023, then jumped by 2255.49% to $11.2 million in 2024, then jumped by 2727.38% to $316.3 million in 2025, then sank by 107.57% to -$23.9 million in 2026.
• The last three EBT figures came in at -$23.9 million (Q1 2026), $316.3 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.